JP2018524390A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018524390A5 JP2018524390A5 JP2018503191A JP2018503191A JP2018524390A5 JP 2018524390 A5 JP2018524390 A5 JP 2018524390A5 JP 2018503191 A JP2018503191 A JP 2018503191A JP 2018503191 A JP2018503191 A JP 2018503191A JP 2018524390 A5 JP2018524390 A5 JP 2018524390A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- group
- acceptable salt
- hydroxyl
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 18
- 150000003839 salts Chemical class 0.000 claims 18
- 239000011780 sodium chloride Substances 0.000 claims 18
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 16
- 125000000623 heterocyclic group Chemical group 0.000 claims 15
- 125000000217 alkyl group Chemical group 0.000 claims 13
- 125000003545 alkoxy group Chemical group 0.000 claims 12
- 125000001424 substituent group Chemical group 0.000 claims 8
- 125000003566 oxetanyl group Chemical group 0.000 claims 7
- 125000005843 halogen group Chemical group 0.000 claims 5
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 4
- -1 2-oxa-6-azaspiro [3.4] octanyl Chemical group 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 125000005842 heteroatoms Chemical group 0.000 claims 2
- 125000002757 morpholinyl group Chemical group 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 125000004193 piperazinyl group Chemical group 0.000 claims 2
- 125000006583 (C1-C3) haloalkyl group Chemical group 0.000 claims 1
- 206010061536 Parkinson's disease Diseases 0.000 claims 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000546 pharmaceutic aid Substances 0.000 claims 1
- 125000003386 piperidinyl group Chemical group 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2015084893 | 2015-07-23 | ||
CNPCT/CN2015/084893 | 2015-07-23 | ||
PCT/CN2016/090962 WO2017012576A1 (en) | 2015-07-23 | 2016-07-22 | Compounds |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2018524390A JP2018524390A (ja) | 2018-08-30 |
JP2018524390A5 true JP2018524390A5 (US20080131398A1-20080605-C00009.png) | 2019-08-29 |
JP6746679B2 JP6746679B2 (ja) | 2020-08-26 |
Family
ID=57833742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018503191A Expired - Fee Related JP6746679B2 (ja) | 2015-07-23 | 2016-07-22 | 化合物 |
Country Status (11)
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3049820A1 (en) * | 2017-01-25 | 2018-08-02 | Glaxosmithkline Intellectual Property Development Limited | Compounds for inhibiting lrrk2 kinase activity |
US20210130339A1 (en) * | 2017-01-25 | 2021-05-06 | Glaxosmithkline Intellectual Property Development Limited | Compounds |
CA3050023A1 (en) * | 2017-01-25 | 2018-08-02 | Glaxosmithkline Intellectual Property Development Limited | Compounds |
US20200002323A1 (en) * | 2017-01-25 | 2020-01-02 | Glaxosmithkline Intellectual Property Development Limited | Compounds |
JP2020505398A (ja) * | 2017-01-25 | 2020-02-20 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited | 化合物 |
CN106866547B (zh) * | 2017-03-15 | 2020-11-10 | 江苏省农用激素工程技术研究中心有限公司 | 2-乙氧基-4,6-二氯嘧啶的合成方法 |
US20200199136A1 (en) * | 2017-08-28 | 2020-06-25 | Acurastem Inc. | Pikfyve kinase inhibitors |
WO2019222173A1 (en) * | 2018-05-15 | 2019-11-21 | E-Scape Bio, Inc. | Fused tetrazoles as lrrk2 inhibitors |
KR20190131981A (ko) * | 2018-05-18 | 2019-11-27 | 재단법인 대구경북첨단의료산업진흥재단 | 외상성 뇌손상 또는 뇌졸중의 예방 또는 치료용 약학적 조성물 |
TWI833770B (zh) | 2018-06-27 | 2024-03-01 | 美商Ionis製藥公司 | 用於減少 lrrk2 表現之化合物及方法 |
EP3873471A4 (en) * | 2018-10-31 | 2022-06-15 | Merck Sharp & Dohme Corp. | N-HETEROARYL INDAZOLE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND THEIR USES |
EP3980412A4 (en) | 2019-06-06 | 2023-05-31 | Merck Sharp & Dohme LLC | INDAZOLE 5-, 6-DISUBSTITUTED, 1-PYRAZOLYL DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF |
WO2021003161A1 (en) * | 2019-07-01 | 2021-01-07 | Curasen Therapeutics, Inc. | Beta adrenergic agonist and methods of using the same |
JP2022540200A (ja) | 2019-07-11 | 2022-09-14 | エスケイプ・バイオ・インコーポレイテッド | Lrrk2阻害剤としてのインダゾールおよびアザインダゾール |
EP4103281A1 (en) * | 2020-02-11 | 2022-12-21 | Acurastem Inc. | Pikfyve kinase inhibitors |
US20230148214A1 (en) * | 2020-03-06 | 2023-05-11 | ESCAPE Bio, Inc. | Indazoles and azaindazoles as lrrk2 inhibitors |
CN115916338A (zh) * | 2020-04-24 | 2023-04-04 | 加利福尼亚大学董事会 | Nurr1受体调节剂及其用途 |
WO2022155419A1 (en) * | 2021-01-15 | 2022-07-21 | ESCAPE Bio, Inc. | Indazoles and azaindazoles as lrrk2 inhibitors |
WO2023076404A1 (en) | 2021-10-27 | 2023-05-04 | Aria Pharmaceuticals, Inc. | Methods for treating systemic lupus erythematosus |
AR127470A1 (es) | 2021-10-27 | 2024-01-31 | H Lundbeck As | Inhibidores de lrrk2 |
US11958865B1 (en) | 2022-09-15 | 2024-04-16 | H. Lundbeck A/S | Leucine-rich repeat kinase 2 (LRRK2) inhibitors |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008516964A (ja) * | 2004-10-15 | 2008-05-22 | メモリー ファーマシューティカルス コーポレーション | ホスホジエステラーゼ4阻害剤としてのピラゾール誘導体 |
AR051596A1 (es) * | 2004-10-26 | 2007-01-24 | Irm Llc | Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios |
JPWO2009157196A1 (ja) * | 2008-06-25 | 2011-12-08 | 武田薬品工業株式会社 | アミド化合物 |
WO2011106168A1 (en) * | 2010-02-24 | 2011-09-01 | Dcam Pharma Inc | Purine compounds for treating autoimmune and demyelinating diseases |
GB201008134D0 (en) * | 2010-05-14 | 2010-06-30 | Medical Res Council Technology | Compounds |
WO2012009258A2 (en) | 2010-07-13 | 2012-01-19 | Edward Roberts | Peptidomimetic galanin receptor modulators |
EP2489663A1 (en) * | 2011-02-16 | 2012-08-22 | Almirall, S.A. | Compounds as syk kinase inhibitors |
JP6242885B2 (ja) | 2012-06-27 | 2017-12-06 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 5−アザインダゾール化合物及び使用方法 |
WO2014134774A1 (en) * | 2013-03-04 | 2014-09-12 | Merck Sharp & Dohme Corp. | Compounds inhibiting leucine-rich repeat kinase enzyme activity |
WO2014134772A1 (en) | 2013-03-04 | 2014-09-12 | Merck Sharp & Dohme Corp. | Compounds inhibiting leucine-rich repeat kinase enzyme activity |
EP3087067B1 (en) | 2013-12-26 | 2018-10-24 | Takeda Pharmaceutical Company Limited | 4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (magl) inhibitors |
EP3190889B1 (en) * | 2014-09-03 | 2021-11-17 | Merck Sharp & Dohme Corp. | Compounds inhibiting leucine-rich repeat kinase enzyme activity |
-
2016
- 2016-07-22 JP JP2018503191A patent/JP6746679B2/ja not_active Expired - Fee Related
- 2016-07-22 CA CA2993269A patent/CA2993269A1/en not_active Abandoned
- 2016-07-22 AU AU2016295604A patent/AU2016295604B2/en not_active Ceased
- 2016-07-22 ES ES16827267T patent/ES2862188T3/es active Active
- 2016-07-22 EP EP16827267.2A patent/EP3325449B1/en active Active
- 2016-07-22 US US15/746,817 patent/US10975081B2/en active Active
- 2016-07-22 BR BR112018001303A patent/BR112018001303A2/pt not_active IP Right Cessation
- 2016-07-22 KR KR1020187004848A patent/KR20180030201A/ko not_active Application Discontinuation
- 2016-07-22 CN CN201680054465.2A patent/CN108137510B/zh not_active Expired - Fee Related
- 2016-07-22 RU RU2018106453A patent/RU2725616C2/ru active
- 2016-07-22 WO PCT/CN2016/090962 patent/WO2017012576A1/en active Application Filing